Redmile Group LLC lowered its position in UnitedHealth Group Inc (NYSE:UNH) by 2.2% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 145,420 shares of the healthcare conglomerate’s stock after selling 3,200 shares during the period. UnitedHealth Group comprises approximately 1.2% of Redmile Group LLC’s holdings, making the stock its 29th largest position. Redmile Group LLC’s holdings in UnitedHealth Group were worth $31,120,000 at the end of the most recent quarter.
Other institutional investors have also recently modified their holdings of the company. Toronto Dominion Bank lifted its stake in UnitedHealth Group by 12.6% in the 4th quarter. Toronto Dominion Bank now owns 432,508 shares of the healthcare conglomerate’s stock worth $95,350,000 after purchasing an additional 48,565 shares in the last quarter. GWM Advisors LLC lifted its stake in UnitedHealth Group by 20.3% in the 4th quarter. GWM Advisors LLC now owns 9,297 shares of the healthcare conglomerate’s stock worth $2,090,000 after purchasing an additional 1,571 shares in the last quarter. Global Financial Private Capital LLC lifted its stake in UnitedHealth Group by 13.7% in the 4th quarter. Global Financial Private Capital LLC now owns 18,386 shares of the healthcare conglomerate’s stock worth $4,053,000 after purchasing an additional 2,212 shares in the last quarter. Intact Investment Management Inc. lifted its stake in UnitedHealth Group by 87.5% in the 1st quarter. Intact Investment Management Inc. now owns 3,000 shares of the healthcare conglomerate’s stock worth $659,000 after purchasing an additional 1,400 shares in the last quarter. Finally, Berkshire Asset Management LLC PA lifted its stake in UnitedHealth Group by 16.2% in the 1st quarter. Berkshire Asset Management LLC PA now owns 11,693 shares of the healthcare conglomerate’s stock worth $2,502,000 after purchasing an additional 1,628 shares in the last quarter. 84.94% of the stock is owned by institutional investors.
Shares of UnitedHealth Group opened at $249.77 on Wednesday, MarketBeat Ratings reports. The stock has a market cap of $244.44 billion, a P/E ratio of 24.80, a PEG ratio of 1.47 and a beta of 0.74. UnitedHealth Group Inc has a 12 month low of $183.86 and a 12 month high of $256.73. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.71 and a current ratio of 0.71.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 17th. The healthcare conglomerate reported $3.04 EPS for the quarter, beating the consensus estimate of $2.91 by $0.13. The company had revenue of $55.19 billion for the quarter, compared to the consensus estimate of $54.90 billion. UnitedHealth Group had a net margin of 5.41% and a return on equity of 22.06%. The firm’s revenue was up 13.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.37 EPS. equities analysts forecast that UnitedHealth Group Inc will post 12.62 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, June 26th. Investors of record on Monday, June 18th were issued a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a yield of 1.44%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $0.75. The ex-dividend date was Friday, June 15th. UnitedHealth Group’s dividend payout ratio is presently 35.75%.
UnitedHealth Group declared that its Board of Directors has approved a share buyback program on Wednesday, June 6th that authorizes the company to repurchase 100,000,000 outstanding shares. This repurchase authorization authorizes the healthcare conglomerate to repurchase shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its shares are undervalued.
Several analysts have commented on the stock. BMO Capital Markets boosted their price target on shares of UnitedHealth Group from $285.00 to $300.00 and gave the stock a “positive” rating in a research note on Thursday, June 21st. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, June 19th. SunTrust Banks assumed coverage on shares of UnitedHealth Group in a research note on Monday, June 11th. They issued a “buy” rating and a $300.00 price target on the stock. ValuEngine upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Wednesday, May 2nd. Finally, Piper Jaffray Companies reiterated a “buy” rating and issued a $270.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 18th. One analyst has rated the stock with a hold rating and twenty-seven have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $259.88.
In related news, Director Kenneth Irwin Shine sold 202 shares of the company’s stock in a transaction dated Thursday, April 19th. The shares were sold at an average price of $237.42, for a total transaction of $47,958.84. Following the transaction, the director now directly owns 28,948 shares in the company, valued at approximately $6,872,834.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the company’s stock in a transaction dated Monday, April 23rd. The shares were sold at an average price of $234.20, for a total transaction of $3,513,000.00. Following the transaction, the director now owns 1,761,533 shares in the company, valued at $412,551,028.60. The disclosure for this sale can be found here. Insiders have sold a total of 49,854 shares of company stock worth $12,295,675 over the last quarter. 0.87% of the stock is currently owned by insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.